Anthony P Polednak1. 1. Connecticut Tumor Registry, Connecticut Department of Public Health, 410 Capitol Avenue, Hartford, CT 06134-0308, USA. anthony.polednak@po.state.ct.us
Abstract
OBJECTIVE: This study examined the temporal trend in late-stage incidence rates for breast and cervical cancer in Connecticut, where a statewide screening program (targeted to poor or uninsured women) began in late 1995. METHODS: Age-standardized incidence rates (ASIRs) for late-stage breast and cervical cancer in Connecticut were analyzed prior to (1988-1991 and 1992-1995) and during (1996-1999) operation of a statewide screening program for lower-income or uninsured women. RESULTS: ASIRs for late-stage cancer declined from the 1988-1991 to 1992-1995, including a reversal in the black-white difference in late-stage breast cancer, while declines from 1992-1995 to 1996-1999 were largely limited to cervical cancer among African American (black) women. CONCLUSIONS: Little progress was evident toward reducing late-stage ASIRs in the 1990s, but continued surveillance is needed to determine if declines in black-white disparities in late-stage cervical cancer ASIRs continue, and to further assess the impact of a statewide screening program.
OBJECTIVE: This study examined the temporal trend in late-stage incidence rates for breast and cervical cancer in Connecticut, where a statewide screening program (targeted to poor or uninsured women) began in late 1995. METHODS: Age-standardized incidence rates (ASIRs) for late-stage breast and cervical cancer in Connecticut were analyzed prior to (1988-1991 and 1992-1995) and during (1996-1999) operation of a statewide screening program for lower-income or uninsured women. RESULTS: ASIRs for late-stage cancer declined from the 1988-1991 to 1992-1995, including a reversal in the black-white difference in late-stage breast cancer, while declines from 1992-1995 to 1996-1999 were largely limited to cervical cancer among African American (black) women. CONCLUSIONS: Little progress was evident toward reducing late-stage ASIRs in the 1990s, but continued surveillance is needed to determine if declines in black-white disparities in late-stage cervical cancer ASIRs continue, and to further assess the impact of a statewide screening program.